Evinova’s Digital Solution will be used by Study Sites to monitor patients enrolled in Quantum Leap’s I-SPY-2.2 at risk of developing interstitial lung disease
Preferences
Would you like to share some personal information with us so we can improve your experience on Researchalize.org?
